Injective becomes SEC-registered transfer agent to support real-world asset tokenization of equities.
Regulation & Gov ·
Injective has obtained SEC registration as a transfer agent, positioning itself to provide compliance infrastructure for real-world asset tokenization. The step follows the launch of Injective markets for tokenized equities tied to private companies, including those tracking SpaceX and OpenAI.
Transfer agent registration typically enables platforms to manage ownership records and settlements for securities. For Injective, the credential removes a regulatory barrier to onboarding institutional capital and issuing tokenized equity products with clearer legal standing than previously available in the space.
The move sharpens Injective's competitive footing in institutional RWA tokenization, though the scale of near-term trading activity on these products and the extent of institutional adoption remain to be determined. Broader questions about how tokenized equities will integrate with existing market infrastructure and custody practices also remain unresolved.